Image

Vasculitis Pregnancy Registry

Recruiting
18 - 50 years of age
Female
Phase N/A

Powered by AI

Overview

The purpose of this study is to learn about the experience of women with vasculitis who become pregnant. In particular, the study will consist of several online surveys to assess

  1. each woman's vasculitis severity and pregnancy-related experiences, and
  2. pregnancy outcomes.

Description

The study will consist of several on-line surveys to assess each woman's vasculitis severity, pregnancy-related experiences, and pregnancy outcomes. Participants will be asked to complete questionnaires at study entry, during the second trimester, during the third trimester, and postpartum. Investigators estimate that it will take approximately 20 minutes to complete each survey. The survey is available in Spanish, Portuguese, Italian, and Turkish.

All women enrolled in the Vasculitis Patient-Powered Research Network (VPPRN) (with specified disease, sex, and age inclusion criteria described below) will be invited via email to participate in this on-line study. The survey data will be stored by the Data Management and Coordinating Center (DMCC) at the University of South Florida. Upon conclusion of the study period, the data will be sent to the Study Chairs.

Eligibility

Inclusion Criteria:

  1. Women 18 years of age or older with one of the following diseases may take part in the
    study
    • Behçet's disease;
    • Central nervous system (CNS) vasculitis;
    • Cryoglobulinemic vasculitis (Cryoglobulinemia);
    • Eosinophilic granulomatosis with polyangiitis (also called Churg-Strauss Syndrome);
    • Giant Cell (Temporal) Arteritis (GCA);
    • Granulomatosis with polyangiitis (also called Wegener's);
    • IgA vasculitis (Henoch-Schoenlein purpura);
    • Microscopic polyangiitis (MPA);
    • Polyarteritis nodosa (PAN);
    • Takayasu's arteritis (TAK);
    • Urticarial vasculitis;
    • Other/Suspected Diagnosis.
  2. Women must be pregnant (self-report) at the time of enrollment into the registry.

Exclusion Criteria:

  1. Non-English speaking, with the exception of people who speak Spanish, Portuguese, Italian, or Turkish.
  2. Unable to provide consent.

Study details

Vasculitis, Behcet's Disease, CNS Vasculitis, Cryoglobulinemic Vasculitis, Eosinophilic Granulomatosis With Polyangiitis (EGPA)

NCT02593565

University of Pennsylvania

8 June 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.